OpGen Combines Genome Maps, Sequencing for De Novo Assembly, Outbreak Analysis | GenomeWeb

While OpGen's optical mapping technology is gaining traction for the assembly of genomes large and small, the company is also honing it for managing disease outbreaks and hospital-acquired infections.

So far, the Gaithersburg, Md.-based firm has placed about 40 of its Argus Whole Genome Mapping systems at customer sites, Richard Moore, OpGen's CSO, told In Sequence earlier this month. OpGen launched the system, which sells for approximately $200,000, in 2011.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.